Literature DB >> 19842793

HIV type 1 fails to trigger innate immune factor synthesis in differentiated oral epithelium.

Wipawee Nittayananta1, Florian Hladik, Mitchell Klausner, Socorro Harb, Beverly A Dale, Robert W Coombs.   

Abstract

The oral mucosa is relatively resistant to human immunodeficiency virus type 1 (HIV-1) transmission. The mechanisms contributing to this resistance remain incompletely understood, but may include HIV-induced synthesis of innate immune factors. We used fully differentiated oral epithelium as a surrogate for the oral mucosa in vivo, exposed it to X4- and R5-tropic HIV-1 in culture, and quantified mRNA expression of six innate immune factors. Neither virus increased expression of human beta defensin 2 (hBD-2) mRNA over supernatants from uninfected lymphoblast controls. HIV-1 also failed to induce mRNA of four additional innate immunity-related genes. Similar results were obtained with oral monolayer epithelial cells. Interestingly, the X4-tropic virus inhibited mRNA expression of hBD-2, and of three of the other factors, at higher dosages in the differentiated oral epithelium but not the monolayers. The failure of HIV-1 to induce innate immune factors in the differentiated epithelium was not due to a lack of tissue penetration, as we detected fluorescence-tagged virions up to 30 mum deep from the apical surface. HIV-1 does not trigger de novo innate immune factor synthesis in oral epithelium, pointing to the role of a constitutive innate immunity for protection against HIV-1 in the oral cavity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19842793      PMCID: PMC2828236          DOI: 10.1089/aid.2009.0032

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  24 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

2.  Expression of the secretory leukoprotease inhibitor gene in epithelial cells.

Authors:  T Abe; N Kobayashi; K Yoshimura; B C Trapnell; H Kim; R C Hubbard; M T Brewer; R C Thompson; R G Crystal
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

Review 3.  Defensins: antimicrobial peptides of innate immunity.

Authors:  Tomas Ganz
Journal:  Nat Rev Immunol       Date:  2003-09       Impact factor: 53.106

Review 4.  Chemokines and T lymphocytes: more than an attraction.

Authors:  S G Ward; K Bacon; J Westwick
Journal:  Immunity       Date:  1998-07       Impact factor: 31.745

5.  Expression of the peptide antibiotic human beta-defensin 1 in cultured gingival epithelial cells and gingival tissue.

Authors:  S Krisanaprakornkit; A Weinberg; C N Perez; B A Dale
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

6.  Plasma viremia in human immunodeficiency virus infection.

Authors:  R W Coombs; A C Collier; J P Allain; B Nikora; M Leuther; G F Gjerset; L Corey
Journal:  N Engl J Med       Date:  1989-12-14       Impact factor: 91.245

Review 7.  The balance between IL-1 and IL-1Ra in disease.

Authors:  William P Arend
Journal:  Cytokine Growth Factor Rev       Date:  2002 Aug-Oct       Impact factor: 7.638

8.  Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication.

Authors:  Miguel E Quiñones-Mateu; Michael M Lederman; Zhimin Feng; Bikram Chakraborty; Jan Weber; Hector R Rangel; Michael L Marotta; Muneer Mirza; Bin Jiang; Patti Kiser; Kathy Medvik; Scott F Sieg; Aaron Weinberg
Journal:  AIDS       Date:  2003-11-07       Impact factor: 4.177

9.  Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements.

Authors:  M Miyamoto; T Fujita; Y Kimura; M Maruyama; H Harada; Y Sudo; T Miyata; T Taniguchi
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

10.  Dose-dependent systemic human immunodeficiency virus infection of SCID-hu mice after intraperitoneal virus injection.

Authors:  M Grandadam; J Y Cesbron; D Candotti; D Vinatier; M Pauchard; A Capron; P Debré; J M Huraux; B Autran; H Agut
Journal:  Res Virol       Date:  1995 Mar-Apr
View more
  3 in total

1.  Expression of oral secretory leukocyte protease inhibitor in HIV-infected subjects with long-term use of antiretroviral therapy.

Authors:  Wipawee Nittayananta; Marisa Kemapunmanus; Supaporn Yangngam; Sineepat Talungchit; Hutcha Sriplung
Journal:  J Oral Pathol Med       Date:  2012-11-06       Impact factor: 4.253

Review 2.  In vitro three-dimensional organotypic culture models of the oral mucosa.

Authors:  Mitchell Klausner; Yuki Handa; Seiya Aizawa
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-01-14       Impact factor: 2.416

3.  Evidence of an increased pathogenic footprint in the lingual microbiome of untreated HIV infected patients.

Authors:  Angeline T Dang; Sean Cotton; Sumathi Sankaran-Walters; Chin-Shang Li; Chia-Yuan Michael Lee; Satya Dandekar; Bruce J Paster; Michael D George
Journal:  BMC Microbiol       Date:  2012-07-28       Impact factor: 3.605

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.